CT VQ is better than Nuclear VQ and can be summarised as: faster to perform, cheaper for patients and providers, safer for patients and providers, easier to perform, better and easier to interpret output, scalable, no disposal of radioactive waste, no new equipment required.
It’s far from just an idea. It’s on the cusp of FDA submission following successful clinical studies as presented at RSNA.
4DX Price at posting:
58.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)